221 related articles for article (PubMed ID: 32106374)
21. Role of microRNA-141-3p in the progression and metastasis of hepatocellular carcinoma cell.
Hou X; Yang L; Jiang X; Liu Z; Li X; Xie S; Li G; Liu J
Int J Biol Macromol; 2019 May; 128():331-339. PubMed ID: 30695725
[TBL] [Abstract][Full Text] [Related]
22. Identification of the Pathogenic Biomarkers for Hepatocellular Carcinoma Based on RNA-seq Analyses.
Jiang W; Zhang L; Guo Q; Wang H; Ma M; Sun J; Chen C
Pathol Oncol Res; 2019 Jul; 25(3):1207-1213. PubMed ID: 30680535
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatics approach to predict target genes for dysregulated microRNAs in hepatocellular carcinoma: study on a chemically-induced HCC mouse model.
Del Vecchio F; Gallo F; Di Marco A; Mastroiaco V; Caianiello P; Zazzeroni F; Alesse E; Tessitore A
BMC Bioinformatics; 2015 Dec; 16():408. PubMed ID: 26652480
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms of pathogenesis in hepatocellular carcinoma revealed by RNA‑sequencing.
Liu Y; Yang Z; Du F; Yang Q; Hou J; Yan X; Geng Y; Zhao Y; Wang H
Mol Med Rep; 2017 Nov; 16(5):6674-6682. PubMed ID: 28901494
[TBL] [Abstract][Full Text] [Related]
26. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
27. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1.
Yang PW; Lu ZY; Pan Q; Chen TT; Feng XJ; Wang SM; Pan YC; Zhu MH; Zhang SH
Phytomedicine; 2019 Apr; 57():18-29. PubMed ID: 30668319
[TBL] [Abstract][Full Text] [Related]
29. The expression profiling and ontology analysis of non-coding RNAs in dexamethasone induced steatosis in hepatoma cell.
Liu F; Gong R; Lv X; Li H
Gene; 2018 Apr; 650():19-26. PubMed ID: 29409992
[TBL] [Abstract][Full Text] [Related]
30. Integrative analysis of transcriptome and miRNome unveils the key regulatory connections involved in different stages of hepatocellular carcinoma.
Ramesh V; Ganesan K
Genes Cells; 2016 Sep; 21(9):949-65. PubMed ID: 27465470
[TBL] [Abstract][Full Text] [Related]
31. Functional lncRNA-miRNA-mRNA Networks in Response to Baicalein Treatment in Hepatocellular Carcinoma.
Zhao X; Tang D; Chen X; Chen S; Wang C
Biomed Res Int; 2021; 2021():8844261. PubMed ID: 33511213
[TBL] [Abstract][Full Text] [Related]
32. Gene expression, regulation of DEN and HBx induced HCC mice models and comparisons of tumor, para-tumor and normal tissues.
Tang Q; Wang Q; Zhang Q; Lin SY; Zhu Y; Yang X; Guo AY
BMC Cancer; 2017 Dec; 17(1):862. PubMed ID: 29254483
[TBL] [Abstract][Full Text] [Related]
33. Identification of the miRNA-mRNA regulatory network of small cell osteosarcoma based on RNA-seq.
Xie L; Liao Y; Shen L; Hu F; Yu S; Zhou Y; Zhang Y; Yang Y; Li D; Ren M; Yuan Z; Yang Z
Oncotarget; 2017 Jun; 8(26):42525-42536. PubMed ID: 28477009
[TBL] [Abstract][Full Text] [Related]
34. miR-589-5p inhibits MAP3K8 and suppresses CD90
Zhang X; Jiang P; Shuai L; Chen K; Li Z; Zhang Y; Jiang Y; Li X
J Exp Clin Cancer Res; 2016 Nov; 35(1):176. PubMed ID: 27835990
[TBL] [Abstract][Full Text] [Related]
35. Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Hepatocellular Carcinoma by Integrated Microarray Analysis.
Lin X; Chen Y
Med Sci Monit Basic Res; 2018 Apr; 24():70-78. PubMed ID: 29706616
[TBL] [Abstract][Full Text] [Related]
36. Integrated bioinformatics analysis revealed the regulation of angiogenesis by tumor cells in hepatocellular carcinoma.
Huo M; Yu K; Zheng Y; Liu L; Zhao H; Li X; Huang C; Zhang J
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34151937
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of miR-33a-5p in Hepatocellular Carcinoma: A Possible Mechanism for Chemotherapy Resistance.
Meng W; Tai Y; Zhao H; Fu B; Zhang T; Liu W; Li H; Yang Y; Zhang Q; Feng Y; Chen G
Med Sci Monit; 2017 Mar; 23():1295-1304. PubMed ID: 28291769
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics study.
Liang L; Zeng JH; Wang JY; He RQ; Ma J; Chen G; Cai XY; Hu XH
Pathol Res Pract; 2017 Dec; 213(12):1494-1509. PubMed ID: 29113686
[TBL] [Abstract][Full Text] [Related]
39. miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.
Chen M; Hu W; Xiong CL; Qu Z; Yin CQ; Wang YH; Luo CL; Guan Q; Yuan CH; Wang FB
Oncotarget; 2016 Dec; 7(49):80751-80764. PubMed ID: 27811373
[TBL] [Abstract][Full Text] [Related]
40. An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells.
Tang S; Tan G; Jiang X; Han P; Zhai B; Dong X; Qiao H; Jiang H; Sun X
Oncotarget; 2016 Nov; 7(45):73257-73269. PubMed ID: 27689326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
